Joint pain and fatigue are actually the biggest issues for people living with haemochromatosis, but we in rheumatology don’t have organized care for them. A call to action from Patrick Kiely, to do better by these patients #EULAR2025 @RheumNow https://t.co/h3Zvov642L

Manifestations of relapsing polychondritis @Lupusreference @RheumNow #EULAR2025 https://t.co/EuPOdKKjax

The ‘iron fist’ of haemochromatosis arthropathy, and other key features: Patrick Kiely #EULAR2025 @RheumNow https://t.co/grs1Tq3GAk

Which CAR-based strategies would you consider to treat severe refractory #SLE based on data presented at #EULAR2025? @RheumNow

POETYK PsA-1 Deucravacitinib TYK2i RCT Ph 3 ACR 20 DEU 54% vs. 34% PBO wk 16 ACR 50 DEU 23% vs. 14% PBO also significant diff for HAQ-DI PASI 75 SF-36 PCS and MDA Less Rx progression @RheumNow #EULAR2025 LB0001 https://t.co/oRLlHwI4Bh

Why do we need RA treatment recommendation updates? We keep on getting new data, for our keystone disease so today Josef Smolen and colleagues present the new 2025 EULAR recommendations #EULAR2025 @RheumNow https://t.co/OdHL8CAIKv

#ClinicalPearls For #cartilage #swelling in #relapsing #polychrondritis Ask for #pics #Levamisole in #cocaine #infection - uncommon - from piercing Acute #bacterial v chronic #lymphoma #malignancy #vasculitis #Trauma Hx, duration, fever can be helpful #EULAR2025 @RheumNow https://t.co/X2b6VHYsYa

RCT of a digital intervention in RMDs? It was long awaited, and all the lights are green🟢! German national Bechterew-App RCT of App based intervention AXIA, control group was standard of care 200pts 12wks ASAS20 response 51% vs. 9% ASAS40 response rate 23% vs. 3% BASDAI:

1st #recommendations for #Hemochromatosis #arthropathy #psuedogout #CPPD #calcium #pyrophosphate #arthritis #EULAR2025 #Recommenadations II @RheumNow @eular_org https://t.co/AnE4T2wYoa

67% of HCPs knew of EULAR’s CVD risk guidelines in RMDs—but few could apply them. ✅ Only 13% linked SLE control to CVD risk 🚫 0% picked correct BP/statin use in RA/AS/PsA Barriers? Time, knowledge, and local guideline gaps. POS0410-HPR @RheumNow #EULAR2025